News Detail
CHENNAI, 10 MAY 2020: The Pune-based National Institute of Virology (NIV) has developed an immunological assay — enzyme-linked immunosorbent assay (ELISA) — to detect antibodies that the body develops in response to infection by the SARS-CoV-2 novel coronavirus, an of......
View Details
Source : The Hindu
Related News
- Scientists have discovered potential treatment for nicotine addiction (25-09-2023)
- Immune Cells Vital to Success of Vaccines Against Coronavirus: Study (24-09-2023)
- New target to beat cancer drug resistance (21-09-2023)
- New implantable device carries insulin-producing islet cells to control diabetes (20-09-2023)
- IIT Madras Researchers Developing A Portable, Turnkey Device To Detect Heavy Metals In Soil & Water (20-09-2023)
- Understanding Medicinal Drug Delivery Using Dry Powder Inhalers (DPIs) (20-09-2023)
- Molnupiravir: Concerns raised about possibility of creating new, treatment-resistant versions of the virus (19-09-2023)
- Various PFAS associated with breast, ovary, skin and uterus cancers in women (19-09-2023)
- IIT Jodhpur researchers develop antimicrobial peptide from snake venom (18-09-2023)
- Metformin, a common diabetes drug, can prevent muscle atrophy and fibrosis (17-09-2023)